Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August

Rhea-AI Summary

Magenta Therapeutics (Nasdaq: MGTA) announced its participation in two upcoming August investor conferences. The company will present at the BTIG Virtual Biotechnology Conference on August 9 at 12:00 p.m. ET and will also be featured in a panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10 at 9:10 a.m. ET. Magenta focuses on developing stem cell transplant therapies for blood cancers, genetic, and autoimmune diseases. For further details, visit Magenta's website.

Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following August investor conferences:

• BTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9
• 2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written - Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10

Additional information can be found on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations.

About Magenta Therapeutics

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005378/en/

FAQ

What conferences will Magenta Therapeutics attend in August 2021?

Magenta Therapeutics will attend the BTIG Virtual Biotechnology Conference on August 9 and the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10.

When is Magenta's presentation at the BTIG Virtual Biotechnology Conference?

Magenta's presentation at the BTIG Virtual Biotechnology Conference is scheduled for August 9 at 12:00 p.m. ET.

What time is Magenta's panel discussion at the Wedbush PacGrow Healthcare Virtual Conference?

Magenta's panel discussion at the 2021 Wedbush PacGrow Healthcare Virtual Conference will take place on August 10 at 9:10 a.m. ET.

What is the main focus of Magenta Therapeutics?

Magenta Therapeutics is focused on developing therapies that harness the curative power of stem cell transplants for patients with blood cancers, genetic diseases, and autoimmune diseases.

Where can I find more information about Magenta Therapeutics?

Additional information about Magenta Therapeutics can be found on their official website at https://investor.magentatx.com/events-and-presentations.